| アブストラクト | The current study aimed to identify the crude drugs associated with drug-induced liver injury (DILI) in 148 Kampo medicines prescribed throughout Japan using the Japanese Adverse Drug Event Report (JADER) database, a large-scale spontaneous reporting system in Japan. First, we tabulated the number of DILI reports from the report-based dataset and the background information from the patient-based dataset. Thereafter, we combined the 126 crude drugs into 104 crude drug groups to examine multicollinearity. Finally, the reporting odds ratios (RORs), 95% confidence intervals, p values for Fisher's exact test, and number of reports were calculated for each crude group to identify those associated with DILI. Notably, the number of adverse event reports for DILI (63,955) exceeded that for interstitial lung disease (51,347), the most common adverse event. In total, 78 crude drug groups (90 crude drugs) were reported to have an ROR > 1, a p < 0.05, and >/=10 reported cases. Our results highlight DILI as an essential issue, given that it was among the most frequently reported adverse drug reactions. We were able to clearly identify the crude drugs associated with DILI, which could help manage adverse drug reactions attributed to Kampo medicines and crude drugs. |
|---|
| ジャーナル名 | Pharmaceuticals (Basel, Switzerland) |
|---|
| Pubmed追加日 | 2023/5/27 |
|---|
| 投稿者 | Kimura, Kyosuke; Kikegawa, Mami; Kan, Yusuke; Uesawa, Yoshihiro |
|---|
| 組織名 | Department of Medical Molecular Informatics, Meiji Pharmaceutical University,;Kiyose 204-8588, Japan.;Datack, Inc., Tokyo 102-0072, Japan.;Department of Kampo Medicine, Yokohama University of Pharmacy, Yokohama 245-0066,;Japan.;Nanohana Pharmacy, Tomakomai 053-0021, Japan. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/37242461/ |
|---|
